Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole vs Fluconazole Prophylaxis in GVHD
NCT00034645Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jan 1999
- Primary completion
- Feb 2003
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of posaconazole in invasive fungal infection (IFI), sponsored by Merck & Co.. Started Jan 1999; status: completed.
02
Drugs
posaconazole
03
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT00034645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00034645.